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The use of mobile telephones has increased
rapidly in recent years. The emission of low-
level radiofrequency electromagnetic fields
leading to the absorption of radiation by the
brain in users of handheld mobile phones has
raised concerns regarding potential effects on
health (Rothman 2000). However, the stud-
ies examining this issue have produced con-
flicting results, and there is ongoing debate
on this issue (Ahlbom et al. 2004; Feychting
et al. 2005). Many of the relevant studies
have been funded by the telecommunications
industry, and thus may have resulted in con-
flicts of interest (Thompson 1993). Recent
systematic reviews of the influence of finan-
cial interests in medical research concluded
that there is a strong association between
industry sponsorship and pro-industry con-
clusions (Bekelman et al. 2003; Yaphe et al.
2001). This association has not been exam-
ined in the context of the studies of potential
adverse effects of mobile phone use. We per-
formed a systematic review and analysis of
the literature to examine whether industry
involvement is associated with the results and
methodologic quality of studies. 
Methods
We searched EMBASE (http://www.embase.
com) and Medline (http://www.ncbi.nlm.
nih.gov/entrez/query.fcgi?DB=pubmed) in
February 2005. Key and free text words
included “cell(ular),” “mobile,” “(tele)phone(s)”
in connection with “attention,” “auditory,”
“bioelectric,” “brain physiology,” “cardio-
vascular,” “cerebral,” “circulatory,” “cognitive,”
“EEG,” “health complaint(s),” “hearing,”
“heart rate,” “hormone(s),” “learning,” “mela-
tonin,” “memory,” “neural,” “neurological,”
“nervous system,” “reaction,” “visual,” “symp-
tom(s),” or “well-being.” The search was com-
plemented with references from a specialist
database (ELMAR 2005) and by scrutinizing
reference lists from the relevant publications.
Articles published in English, German, or
French were considered.
We included original articles that reported
studies of the effect of controlled exposure
with radiofrequency radiation on health-
related outcomes [“human laboratory studies”
in World Health Organization (WHO) ter-
minology (Repacholi 1998)]. Health-related
outcomes included electroencephalogram
(EEG) recordings, assessments of cognitive or
cardiovascular function, hormone levels, and
subjective well-being and symptoms. We
excluded studies of the risk of using mobile
phones when driving a motor vehicle or oper-
ating machinery as well as studies on electro-
magnetic ﬁeld (EMF) incompatibilities (e.g.,
pacemakers or hearing aids). Three of us
(A.H., K.H., M.R.) independently extracted
data on the source of funding (industry, public
or charity, mixed, not reported) and potential
confounding factors, including study design
(crossover, parallel, other), exposure (fre-
quency band, duration, field intensity, and
location of antenna), and methodologic and
reporting quality. Four dimensions of quality
were assessed (Jüni et al. 2001; Repacholi
1998): a) randomized, concealed allocation of
study participants in parallel or crossover tri-
als; b) blinding of participants and investiga-
tors to allocation group; c) reporting of the
speciﬁc absorption rate (SAR; watts per kilo-
gram tissue) from direct measurement using a
phantom head or three-dimensional dosimet-
ric calculations (“appropriate exposure set-
ting”); d) appropriate statistical analysis. For
each item, studies were classiﬁed as adequate
or inadequate/unclear. 
The primary outcome was the reporting of
at least one statistically signiﬁcant (p < 0.05)
association between radiofrequency exposure
and a health-related outcome. The message in
the title was also assessed. We distinguished
among neutral titles [e.g., “Human brain
activity during exposure to radiofrequency
fields emitted by cellular phones” (Hietanen
et al. 2000)], titles indicating an effect of radi-
ation [e.g., “Exposure to pulsed high-fre-
quency electromagnetic field during waking
affects human sleep EEG” (Huber et al.
2000)], and titles stating that no effect was
shown [e.g., “No effect on cognitive function
from daily mobile phone use” (Besset et al.
2005)]. Finally, authors’ declaration of con-
ﬂicts of interest (present, absent) and afﬁlia-
tions (industry, other) were recorded.
Differences in data extracted by A.H., K.H.,
and M.R. were resolved in the group, with the
senior epidemiologist (M.R.) acting as the
arbiter. In addition, two of us (K.H.M.,
M.E.), who were kept blind to funding
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exclusively by industry reported the largest number of outcomes, but were least likely to report a
statistically signiﬁcant result: The odds ratio was 0.11 (95% conﬁdence interval, 0.02–0.78), com-
pared with studies funded by public agencies or charities. This ﬁnding was not materially altered in
analyses adjusted for the number of outcomes reported, study quality, and other factors. 
CONCLUSIONS: The interpretation of results from studies of health effects of radiofrequency radiation
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extraction of data from abstracts and assess-
ments of titles. Differences in data extracted by
K.H.M. and M.E. were resolved with the
senior epidemiologist (M.E.) acting as the
arbiter. Based on the abstracts, we assessed
whether authors interpreted their study results
as showing an effect of low-level radiofrequency
radiation, as showing no effect, or as indicating
an unclear ﬁnding.
We used logistic regression models to assess
whether the source of funding was associated
with the reporting of at least one significant
effect in the article (including the abstract). We
examined the influence of potential con-
founders, such as the total number of out-
comes that were reported in the article, the
type of study (crossover, parallel, other), the
four dimensions of study quality (adequate or
not adequate/unclear), exposure conditions
(position of the antenna next to the ear com-
pared with other locations; use of the 900-
MHz band compared with other bands;
duration of exposure in minutes), as well as
the type of outcome (e.g., cognitive function
tests: yes vs. no). Variables were entered one
at a time and, given the limited number of
studies, models were adjusted for one variable
only. Results are reported as odds ratios
(ORs) with 95% conﬁdence intervals  (CIs).
All analyses were carried out in Stata (version
8.2; StataCorp., College Station, TX, USA). 
Results
We identified 222 potentially relevant
publications and excluded 163 studies that
did not meet inclusion criteria (Figure 1). We
excluded one study that had been funded by a
company producing “shielding” devices that
reduce EMF exposure (Croft et al. 2002). A
total of 59 studies were included: 12 (20%)
were exclusively funded by the telecommuni-
cations industry, 11 (19%) were funded by
public agencies or charities, 14 (24%) had
mixed funding (including industry and indus-
try-independent sources), and in 22 (37%)
studies the source of funding was not reported.
None of 31 journals published a statement on
possible conﬂicts of interest of the 287 authors
listed in the bylines. Five (8%) studies had
authors with industry affiliation. All studies
except two (3%) were published in journals
that use peer review, and one was published in
a journal supplement. The bibliographic refer-
ences are given in the Supplemental Material
(http://www.ehponline.org/members/2006/
9149/supplemental.pdf).
Blinded and open extraction of data
yielded identical results with respect to the
reporting of statistically significant effects in
the abstract and the message of the title. Study
characteristics are shown in Table 1. All studies
were published during 1995–2005, with the
number of publications increasing from one to
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Table 1. Characteristics of 59 experimental studies of the effects of exposure to low-level radiofrequency
electromagnetic ﬁelds.
Source of funding
Industry  Public or charity  Mixed  Not reported 
Study characteristic (n = 12) (n = 11) (n = 14) (n = 22)
Study design [no. (%)]
Crossover trial 10 (83.3) 7 (63.6) 12 (85.7) 11 (50)
Parallel group trial 0 (0) 2 (18.2) 1 (7.1) 2 (9.1)
Other, unclear 2 (16.7) 2 (18.2) 1 (7.1) 9 (40.9)
Exposure [no. (%)]
Location of antenna 
Next to ear 4 (33.3) 8 (72.7) 11 (78.6) 14 (63.6)
Other/unclear 8 (66.7) 3 (27.3) 3 (21.4) 8 (36.4)
Frequency banda
900 MHz 11 (91.7) 8 (72.7) 13 (92.9) 14 (63.6)
Other frequencies 2 (16.7) 7 (63.6) 0 (0) 5 (22.7)
Unclear 0 (0) 0 (0) 1 (7.1) 5 (22.7)
Median duration of exposure (range) 180 (3–480) 20 (5–35) 45 (30–240) 30 (4–480)
Outcomes assessed [no. (%)]a
Electroencephalogram  7 (58.3) 5 (45.5) 8 (57.1) 12 (54.5)
Cognitive function tests  0 (0) 3 (27.3) 8 (57.1) 8 (36.4)
Hormone levels 5 (41.7) 0 (0) 0 (0) 2 (9.1)
Cardiovascular function 2 (16.7) 1 (9.1) 0 (0) 2 (9.1)
Well-being or symptoms 1 (8.3) 1 (9.1) 1 (7.1) 0 (0)
Other  4 (33.3) 3 (27.3) 1 (7.1) 3 (13.6)
Study quality [no. (%)]a
Randomization adequate 10 (83.3) 7 (63.6) 13 (92.9) 9 (40.9)
Participants and assessors blinded 1 (8.3) 3 (27.3) 8 (57.1) 3 (13.6)
SAR determined 4 (33.3) 4 (36.4) 8 (57.1) 2 (9.1)
Statistical analysis adequate 3 (25) 3 (27.3) 7 (50) 1 (4.5)
Median study size (range) 21 (8–38) 24 (13–100) 20 (13–96) 20 (8–78)
Percentages are column percentages. 
aThe same study could be listed in more than one category.
Figure 1. Identiﬁcation of eligible studies.
Potentially eligible articles identified
(n = 222)
80 full-text articles examined
59 studies included in analyses
Exclusions based on title or abstract
(n = 142)
Studies of the risk of using mobile phones when driving
a motor vehicle or operating machinery
(n = 29)
Studies of the use of mobile phones in the monitoring
of and communication with patients
(n = 28)
Other study designs
(n = 29)
Studies of interference with hearing aids or pacemakers
(n = 28)
Studies of other exposures or methodologic issues
(n = 26)
Animal studies
(n = 2)
•
•
•
•
•
•
Excluded
(n = 21)
Other study design
(n = 9)
Published in Chinese or Russian
(n = 3)
Publication was withdrawn
(n = 1)
Double publications
(n = 5)
Studies of reducing exposure (”shielding studies”)
(n = 2)
Funded by company producing “shielding devices”
(n = 1)
•
•
•
•
•
•Source of funding and studies of mobile phone use
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two publications per year to 11 publications in
2004. Median year of publication was 1998 for
industry-funded studies, 2002 for public or
charity funding and studies with mixed fund-
ing sources, and 2003 for studies that did not
report their funding source. The median size of
all the studies was small (20 study partici-
pants); most studies (n = 32, 54%) were of a
crossover design and mimicked the exposure
situation during a phone call, using the 900-
MHz band with the antenna located close to
the ear. Exposure duration ranged from 3 to
480 min, with a median of 33 minutes.
Thirty-three (59%) studies measured outcomes
during exposure, 14 (24%) postexposure, and
12 (20%) at both times. Thirty-nine (66%)
studies prevented selection bias with adequate
randomization; 15 (25%) blinded both partici-
pants and assessors; in 18 (31%) the field
intensity had been assessed appropriately, with
SAR values ranging from 0.03 to 2 W/kg tis-
sue. Finally, in 14 (24%) studies we considered
the statistical analysis to be adequate. Study
quality varied by source of funding: Studies
with mixed funding (including public agencies
or charities and industry) had the highest qual-
ity, whereas studies with no reported source of
funding did worst (Table 1).
Forty (68%) studies reported one or more
statistically signiﬁcant results (p < 0.05) indi-
cating an effect of the exposure (Table 2).
Studies funded exclusively by industry reported
on the largest number of outcomes but were
less likely to report statistically significant
results: The OR for reporting at least one such
result was 0.11 (95% CI, 0.02–0.78), com-
pared with studies funded by public agencies
or charities (Table 3). This finding was not
materially altered in analyses adjusted for the
number of outcomes reported, study design
and quality, exposure characteristics, or out-
comes [Table 3; see Supplemental Material,
Table 1 (http://www.ehponline.org/members/
2006/9149/supplemental.pdf)]. Similar
results were obtained when restricting analy-
ses to results reported in abstracts (OR =
0.29; 95% CI, 0.05–1.59) or on the conclu-
sions in the abstract (OR = 0.10, 95% CI,
0.009–1.10). Thirty-seven (63%) studies had
a neutral title, 11 (19%) a title reporting an
effect, and 11 (19%) a title reporting no effect
(Table 2). 
Discussion
We examined the methodologic quality and
results of experimental studies investigating
the effects of the type of radiofrequency radia-
tion emitted by handheld cellular telephones.
We hypothesized that studies would be less
likely to show an effect of the exposure if
funded by the telecommunications industry,
which has a vested interest in portraying the
use of mobile phones as safe. We found that
the studies funded exclusively by industry
were indeed substantially less likely to report
statistically significant effects on a range of
end points that may be relevant to health. 
Our ﬁndings add to the existing evidence
that single-source sponsorship is associated with
outcomes that favor the sponsors’ products
(Bekelman et al. 2003; Davidson 1986;
Lexchin et al. 2003; Stelfox et al. 1998). Most
previous studies of this issue were based on
studies of the efﬁcacy and cost-effectiveness of
drug treatments. A recent systematic review and
meta-analysis showed that studies sponsored by
the pharmaceutical industry were approxi-
mately four times more likely to have outcomes
favoring the sponsor’s drug than studies with
other sources of funding (Lexchin et al. 2003).
The inﬂuence of the tobacco industry on the
research it funded has also been investigated
(Barnes and Bero 1996, 1998; Bero 2005). To
our knowledge, this is the ﬁrst study to examine
this issue in the context of exposure to radiofre-
quency electromagnetic ﬁelds. 
Our study has several limitations. We
restricted our analysis to human laboratory
studies. This resulted in a more homogenous
set of studies, but may have reduced the sta-
tistical power to demonstrate or exclude
smaller associations. The WHO has identiﬁed
the need for further studies of this type to
clarify the effects of radiofrequency exposure
on neuroendocrine, neurologic, and immune
systems (Foster and Repacholi 2004). We
considered including epidemiologic studies
but found that practically all of them were
publicly funded. The study’s primary out-
come—the reporting of statistically signiﬁcant
associations—is a crude measure that ignores
the size of reported effects. However, we
found the same trends when assessing the
authors’ conclusions in the abstracts. 
Although we have shown an association
between sponsorship and results, it remains
unclear which type of funding leads to the
most accurate estimates of the effects of
Table 2. Results from assessments of article text, abstract, and title of 59 experimental studies of the
effects of exposure to low-level radiofrequency electromagnetic ﬁelds.
Source of funding
Industry  Public or charity  Mixed  Not reported
(n = 12) (n = 11) (n = 14) (n = 22)
Article text
No. (%) of studies with at least one result  4 (33) 9 (82) 10 (71) 17 (77)
suggesting an effect at p < 0.05
Median no. (range) of outcomes reported 17.5 (4–31) 10 (1–80) 16 (9–44) 7 (1–35)
Median no. (range) of outcomes  0 (0–6) 1.5 (0–7) 3 (0–15) 1.5 (0–12)
suggesting an effect at p < 0.05
Abstracta (n = 12) (n = 11) (n = 14) (n = 20)
No. (%) of studies with at least one result  4 (33) 7 (64) 10 (71) 15 (75)
suggesting a signiﬁcant effect 
Median no. (range) of outcomes reported  3.5 (1–36) 3 (1–5) 6.5 (3–44) 3 (1–64)
Median no. (range) of outcomes  0 (0–6) 1 (0–3) 2 (0–5) 1.5 (0–7)
suggesting a signiﬁcant effect
Authors’ interpretation of results [no. (%)]
No effect of radiofrequency radiation 10 (83.3) 5 (45.5) 4 (28.6) 5 (22.7)
Effect of radiofrequency radiation 1 (8.3) 5 (45.5) 8 (57.1) 14 (63.6)
Unclear ﬁnding 1 (8.3) 1 (9) 2 (14.3) 3 (13.6)
Title [no. (%)]
Neutral 7 (58) 5 (46) 8 (57) 17 (77)
Statement of effect 0 (0) 4 (36) 3 (21) 4 (18)
Statement of no effect 5 (42) 2 (18) 3 (21) 1 (5)
Percentages are column percentages. 
aTwo publications that did not report their source of funding had no abstracts. 
Table 3. Probability of reporting at least one statistically signiﬁcant result (p < 0.05) according to source of
funding: crude and adjusted ORs (95% CIs) from logistic regression models. 
Source of funding
Industry  Public or charity  Mixed  Not reported 
(n = 12) (n = 11) (n = 14) (n = 22) p-Valuea
Crude 0.11 (0.02–0.78) 1 (reference) 0.56 (0.08–3.80) 0.76 (0.12–4.70) 0.04 
Adjusted for
No. of reported outcomes  0.12 (0.02–0.89) 1 (reference) 0.60 (0.08–4.28) 0.96 (0.15–6.23) 0.04
Median study size 0.08 (0.009–0.62) 1 (reference) 0.61 (0.08–4.59) 0.57 (0.08–4.02) 0.02
Study design (crossover, parallel,  0.08 (0.01–0.68) 1 (reference) 0.38 (0.05–3.07) 1.16 (0.16–8.61) 0.029
or other)
Study quality
Randomization adequate  0.04 (0–0.56) 1 (reference) 0.16 (0.01–2.15) 1.27 (0.16–9.89) 0.005
Participants and assessors blinded 0.14 (0.02–0.96) 1 (reference) 0.54 (0.08–3.91) 0.76 (0.12–4.8) 0.09
Statistical analysis adequate 0.12 (0.02–0.85) 1 (reference) 0.67 (0.09–4.85) 0.54 (0.08–3.76) 0.07
Exposure setting appropriate 0.13 (0.02–0.89) 1 (reference) 0.47 (0.07–3.39) 0.86 (0.14–5.5) 0.06
Models adjusted for one variable at a time.
aFrom likelihood ratio tests. radiofrequency radiation. For example, if
researchers with an environmentalist agenda
are more likely to be funded by public agen-
cies or charities, then their bias may result in
an overestimation of effects. Interestingly,
studies with mixed funding were of the high-
est quality. The National Radiological
Protection Board (NRPB 2004) reviewed
studies of health effects from radiofrequency
(RF) ﬁelds and concluded that “scientiﬁc evi-
dence regarding effects of RF field exposure
from mobile phones on human brain activity
and cognitive function … has included results
both supporting and against the hypothesis of
an effect.” We found that the source of fund-
ing explains some of the heterogeneity in the
results from different studies. The association
was robust and little affected by potential
confounding factors such as sample size, study
design, or quality. 
Possible explanations for the association
between source of funding and results have
been discussed in the context of clinical
research sponsored by the pharmaceutical
industry (Baker et al. 2003; Bekelman et al.
2003; Lexchin et al. 2003). The association
could reﬂect the selective publication of stud-
ies that produced results that ﬁtted the spon-
sor’s agenda. Sponsors might influence the
design of the study, the nature of the expo-
sure, and the type of outcomes assessed. In
multivariate logistic regression analysis, the
only factor that strongly predicted the report-
ing of statistically significant effects was
whether or not the study was funded exclu-
sively by industry. We stress that our ability
to control for potential confounding factors
may have been hampered by the incomplete
reporting of relevant study characteristics. 
Medical and science journals are imple-
menting policies that require authors to dis-
close their financial and other conflicts of
interest. None of the articles examined here
included such a statement, in line with a survey
of science and medical journals that showed
that adopting such policies does not generally
lead to the publication of disclosure statements
(Krimsky and Rothenberg 2001). A review of
2005 instructions to authors showed that 15
(48%) of the 31 journals included in our study
had conflict of interest policies. Our results
support the notion that disclosure statements
should be published, including statements
indicating the absence of conﬂicts of interest.
The role of the funding source in the design,
conduct, analysis, and reporting of the study
should also be addressed. 
There is widespread concern regarding the
possible health effects associated with the use
of cellular phones, mobile telephone base sta-
tions, or broadcasting transmitters. Most
(68%) of the studies assessed here reported
biologic effects. At present it is unclear
whether these biologic effects translate into
relevant health hazards. Reports from national
and international bodies have recently con-
cluded that further research efforts are needed,
and dedicated research programs have been set
up in the United States, Germany, Denmark,
Hungary, Switzerland, and Japan. Our study
indicates that the interpretation of the results
from existing and future studies of the health
effects of radiofrequency radiation should take
sponsorship into account. 
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